John M. Routes
Department of Medicine and Immunology
National Jewish Center for Immunology and Respiratory Medicine
Denver
CO 80206
USA
Name/email consistency: high
- Macrophages kill human papillomavirus type 16 E6-expressing tumor cells by tumor necrosis factor alpha- and nitric oxide-dependent mechanisms. Routes, J.M., Morris, K., Ellison, M.C., Ryan, S. J. Virol. (2005)
- Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection. Routes, J.M., Ryan, S., Morris, K., Takaki, R., Cerwenka, A., Lanier, L.L. J. Exp. Med. (2005)
- Adenovirus E1A oncogene expression in tumor cells enhances killing by TNF-related apoptosis-inducing ligand (TRAIL). Routes, J.M., Ryan, S., Clase, A., Miura, T., Kuhl, A., Potter, T.A., Cook, J.L. J. Immunol. (2000)
- Dissimilar immunogenicities of human papillomavirus E7 and adenovirus E1A proteins influence primary tumor development. Routes, J.M., Ryan, S., Li, H., Steinke, J., Cook, J.L. Virology (2000)









